Share
Market Research Report

NORTH AMERICA AND EUROPE ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS (ABSSSI) MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By Drug TypeOral & Parenteral Antibiotics (Vancomycin, Linezolid, Clindamycin, Ceftaroline, Daptomycin, Dalbavancin, Tedizolid, Others) · Topical Antibiotics (Hydrogen Peroxide, Fusidic Acid, Mupirocin, Retapamulin, and Povidone-Iodine)
  • By Infection TypeHospital Acquired ABSSSI · Community Acquired ABSSSI
  • By Route of AdministrationOral · Parenteral · and Topical
  • By Distribution ChannelHospital Pharmacies · Retail Pharmacies · and Online Pharmacies
  • By GeographyNorth America · Europe
  • Published In28 Apr 2026
  • Report CodeCMI4273
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Drug Type
      • Market Snapshot, By Infection Type
      • Market Snapshot, By Route of Administration
      • Market Snapshot, By Distribution Channel
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Product Approval
    • Collaboration/Merge/Acquisition
    • Regulatory Landscape
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Epidemiology
    • Robust Pipeline Analysis
  4. North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market, By Drug Type, 2021 – 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022– 2033
      • Segment Trends
    • Oral & Parenteral Antibiotics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
        • Vancomycin
        • Linezolid
        • Clindamycin
        • Ceftaroline
        • Daptomycin
        • Dalbavancin
        • Tedizolid
        • Others
    • Topical Antibiotics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
        • Hydrogen Peroxide
        • Fusidic Acid
        • Mupirocin
        • Retapamulin
        • Povidone-Iodine
  5. North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market, By Infection Type, 2021 – 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Hospital Acquired ABSSSI
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
    • Community Acquired ABSSSI
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
  6. North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market, By Route of Administration, 2021 – 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
    • Parenteral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
    • Topical
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
  7. North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market, By Distribution Channel, 2021 – 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn) 
  8. North America and Europe Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market, By Region, 2021 – 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Regions, 2022–2033
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Mn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
  9. Competitive Landscape

    • Heat Map Analysis
    • Market Share Analysis
    • Company Profile
      • Merck & Co Inc
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Pfizer Inc
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • GlaxoSmithKline plc
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Teva Pharmaceutical Industries Ltd
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Paratek Pharmaceuticals, Inc
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Melinta Therapeutics, Inc.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Arrevus, Inc
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • AbbVie Inc
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Aurobindo Pharma Ltd
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Amneal Pharmaceuticals LLC
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Sun Pharmaceutical Industries Ltd.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
    • Analyst Views
  10. Section

    • References
    • Research Methodology
    • About Us